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Abstract 
The transition between epithelial and mesenchymal (EMT) is a fundamental cellular process 
that plays critical roles in development, cancer metastasis, and tissue wound healing. EMT is 
not a binary process but involves multiple partial EMT states that give rise to a high degree of 
cell state plasticity. Here, we first reviewed several studies on theoretical predictions and 
experimental verification of these intermediate states, the role of partial EMT on kidney fibrosis 
development, and how quantitative signaling information controls cell commitment to partial or 
full EMT upon transient signals. Next, we summarized existing knowledge and open questions 
on the coupling between EMT and other biological processes, such as the cell cycle, epigenetic 
regulation, stemness, and apoptosis. Taken together, EMT is a model system that has attracted 
increasing interests for quantitative experimental and theoretical studies. 
  
		
Introduction  
Epithelial cells are adherent cells that form tightly adherent top layers of cavities, glands, and 
other structures throughout the body. In contrast, mesenchymal cells are loosely connected to 
each other and develop into connective tissues. Transition from the epithelial to the 
mesenchymal phenotype, known as epithelial-to-mesenchymal transition (EMT), is typically 
characterized by loss of cell-cell adhesion and apicobasal polarity and increased cell motility 
and invasion [1, 2]. EMT and the reverse process, mesenchymal-to-epithelial transition (MET), 
play important roles in embryonic development, tissue regeneration, and wound healing [3-5]. 
EMT also takes place in some pathological processes such as cancer progression and fibrosis 
formation in organs including the lungs, liver, and kidney. A plethora of molecular species 
regulate the EMT process at various levels and are potential pharmaceutical targets [6, 7]. 
Therefore, due to the biological importance and biomedical significance of EMT, in recent years 
there has been an explosive growth on the number of EMT-related studies in both physiological 
and pathological contexts. 
Concurrently, EMT has also attracted increasing interests from the biological physics community. 
First, mathematical modeling can help unravel regulatory mechanisms underlying the seemingly 
complex EMT process. At the cellular level, the EMT process involves global reprogramming of 
cell transcriptome, epigenome, chromosome structure, and many phenotypic properties. 
Multiple molecular species form an interconnected intracellular network, and the functional roles 
of each one must be placed in the context of the overall regulatory network. At the tissue level, 
epithelial cells receive cues from diffusive extracellular factors and neighboring cells and make a 
choice on EMT or other cell fates. Combined with quantitative measurements, mathematical 
modeling has emerged as a powerful tool for studying the biology of EMT at different levels. 
Second, EMT as a biological process can also serve as a model system to address physics-
oriented questions such as information transmission and transitions dynamics between multiple 
		
metastable states of a nonlinear dynamical system kept far from thermodynamic equilibrium.  
In this review, we first discuss some studies that use integrated quantitative experiments and 
mathematical modeling to address certain EMT-related questions. We then provide our 
perspectives on a few problems that may attract attention in the near future and the interplay 
between the biology of EMT, nonlinear dynamics, and none-equilibrium physics. Due to the 
length limit, we will restrict our discussions to selected topics and put more focus on our own 
work. We apologize in advance for not mentioning a large number of studies, and the readers 
can find some related discussions from other reviews in this theme issue. 
1. Quantitative studies revealed a stepwise EMT dynamics through intermediate 
states. 
Cancer metastasis causes more than 90% of cancer-related deaths [8]. Therefore, it is a key 
strategy in cancer treatment to reduce the probability of metastasis, for which lack of 
mechanistic understanding of metastasis remains a major limiting factor. Cancer cells in primary 
epithelial solid tumors are epithelial cells that hold tightly with neighboring cells. To metastasize, 
epithelial cancer cells must break such intercellular connections and become more mobile. A 
proposal that received lots of attention is that cancer cells use EMT to convert tightly packed 
solid tumor epithelial cells into migratory mesenchymal cells; the latter enter into the circulatory 
system and become circulating tumor cells (CTCs). Some CTC cells survive the harsh 
environment of the circulatory system, and then manage to leave and transform back into 
epithelial cells through the MET process to serve as seeding cells for metastatic tumor formation 
[3-5, 9-18]. Results from various cancer types support the theory [5, 19-21].  
Multiple lines of evidence, however, also challenge the EMT theory of metastasis. Some mouse 
studies reach a conclusion that EMT is not required for cancer metastasis but contributes to 
chemoresistance in pancreatic and lung cancer with different EMT phenotypes responding to 
		
treatments differently [22, 23]. There are heated debates on how to interpret these results [24, 
25]. Close examination of the two studies reveals that while a complete EMT might not 
significantly contribute to metastasis, the two studies do not rule out incomplete (or partial) EMT 
as a candidate. EMT proceeds through several intermediate phenotypes collectively known as 
the partial EMT (pEMT) state (Fig. 1A) [26-30]. The pEMT state retains some characteristics of 
epithelium but also shows features of mesenchymal cells [31], and CTC cells typically move in 
clusters and possess the pEMT feature [10, 32].  
It turns out the pEMT phenotype also appears in other contexts such as developmental 
processes [33, 34] and fibrosis discussed below. These experimental and clinical observations 
lead to some mechanistic questions: can pEMT exist as one or multiple stable phenotypes, and 
how does it originate? Several theoretical studies have been devoted to unraveling the 
mechanism(s) of generating the multiple EMT-related phenotypes, with a few of them detailed 
below. 
TGF-β is one of the major inducers of EMT and plays essential roles in the developmental and 
normal physiological process. Dysregulation of TGF-β signal leads to complex diseases such as 
cancer, fibrosis, and Alzheimer’s disease. Previous studies identified a core regulatory network 
for TGF-β-induced EMT (Fig. 1B) [35-37]. This network contains two double-negative feedback 
loops: one between transcription factor SNAIL1 and the miR-34 microRNA family, and another 
between transcription factors ZEB1/2 and the miR-200 family.  Based on this network, Tian et al. 
proposed a Cascading Bistable Switches (CBS) mechanism [38]. Through bifurcation analysis, 
the model predicts that TGF-β induced EMT proceeds through two coupled reversible and 
irreversible bistable switches (Fig. 1C). The SNAIL1/miR-34 double-negative feedback loop 
controls the first bistable switch and the transition from the epithelial to the pEMT state. The 
transition is reversible, so when the exogenous TGF-β is removed, cells return to the epithelial 
state. Further increase of the exogenous TGF-β level flips the second bistable switch formed by 
		
the ZEB/miR-200 double-negative feedback loop, and cells change from the pEMT state to the 
fully mesenchymal state. This switch flipping also releases inhibition of miR-200 on endogenous 
TGF-β expression, which makes the second bistable switch irreversible. Subsequent 
experimental studies with human MCF10A cells [39] confirmed several key model predictions, 
and the flow cytometry data in Fig. 2 shows such an example. The E-cadherin/Vimentin two-
color flow cytometry sorts cells into three groups corresponding to epithelial (E with E-
cadherinhighVimentinlow), partial EMT (P with E-cadherinmediumVimentinmedium), and mesenchymal 
(M with E-cadherinlowVimentinhigh) states, respectively. These authors also demonstrated that 
cells maintain the partial EMT phenotype after weeks of culturing under treatment of 
intermediate TGF-β concentration. That is, the pEMT state is a stable phenotype rather than a 
transient intermediate. Cells also segregate into SNAIL1low and SNAIL1high sub-populations 
under intermediate TGF-β concentration (i.e., 0.5 and 1 ng/ml), reflecting the change of the first 
switch. At higher (1 and 2 ng/ml) TGF-β concentration, ZEB1low and ZEB1high sub-populations 
coexist, reflecting the change of the second switch. Therefore, there is a remarkable agreement 
between experimental results and model predictions. Tian et al. made some mathematical 
approximations on modeling the mRNA-miRNA interactions [38], which raised theoretical 
concerns on the existence of the SNAIL1-associated switch. In a revised model [39], the mRNA-
miRNA mutual interactions and the dynamics of individual molecular species were explicitly 
modeled. A more thorough theoretical analysis further confirmed that a generic mRNA-miRNA 
mutual interaction motif can generate rich dynamical patterns including bistability [40]. That is, 
these two follow-up studies support the theoretical conclusion in the original study [38].  
Based on essentially the same core network, Lu et al. proposed a different Ternary Chimera 
Switch (TCS) mechanism and predicted a different partial EMT state [41]. These researchers 
noticed that SNAIL1 acts as its own transcription inhibitor. Therefore, they suggested that the 
SNAIL1-miR-34 module is not a bistable switch but serves as a noise filter to prevent 
		
inadvertent EMT. Instead, they showed that the ZEB/miR-200 feedback loop coupled to a direct 
or indirect self-activation of ZEB form a toggle switch that can generate the three different EMT 
phenotypes. 
It might seem surprising that qualitatively different mechanisms are proposed based on 
essentially the same network. The differences reflect that network dynamics are determined by 
both its topology and parameter values, the latter being more context-dependent. While the 
MCF10A data supports the CBS model, it is possible that the TCS model describes EMT 
dynamics of some other cell lines and cells in specific contexts, where SNAIL1 plays a less 
essential role on generating the pEMT state. From a more abstract level, the two models agree 
that both suggest partial EMT state(s) can arise from combinations of feedback network motifs. 
Moreover, these two models are not necessarily exclusive. Actually, the core regulatory network 
is embedded in a larger EMT network that permits more stable states, analogous to the rugged 
protein folding landscapes. Indeed, Hong et al. identified one additional partial EMT state by 
adding an OVOL2-ZEB positive feedback loop to the core network [42]. A role of OVOL2 in 
stabilizing the partial EMT state was also reported [43, 44]. Computational models for larger 
EMT networks have indeed highlighted the existence of multiple partial EMT states. For 
instance, Boolean models for EMT networks that treat a gene expression level in a discrete way 
to be either ON (1) or OFF (0) identified states co-expressing various epithelial and 
mesenchymal genes [45-47]. Increasing in vitro and in vivo evidence show multiple intermediate 
partial EMT states. Huang et al. analyzed 1,538 ovarian tumors and identified multiple partial 
EMT states [48-50]. Similar plasticity was observed in a panel of non-small cell lung cancer and 
ovarian cancer cell lines [51]. Six intermediate partial EMT states were found during cancer 
metastasis in a skin cancer mouse model in vivo [52].  
Taken together, integrated experimental and theoretical efforts have provided critical insights on 
EMT regulation, especially on the nature and dynamical characteristics of the pEMT state. The 
		
reversibility of the pEMT state is likely necessary for development, resolution after wound 
healing, and cancer metastasis.  
2. Model studies guided experiments to reveal double-edged roles of partial EMT on 
injury repair and fibrosis formation. 
Aside from being observed in cancer metastasis, EMT can also be found in fibrosis progression. 
Fibrosis is formed with excessive deposition of fibrous connective tissues secreted by cells like 
myofibroblasts, often during the process of recovery from injury or fibrogenesis [53]. The latter 
refers to the process of gradual formation and progression of fibrotic patches that interfere with 
normal architecture and function of underlying tissues and organs. Progression of fibrosis is 
generally irreversible and eventually leads to organ failure. Currently, there is no effective 
treatment.  For example, patients that have recovered from acute kidney injuries (AKI) have a 
much higher risk of later developing chronic kidney diseases (CKD) manifested with fibrosis, 
and eventually end-stage renal disease (ESRD) that requires dialysis or kidney transplantation 
[54].  
It is a well-established phenomenon that EMT takes place during fibrogenesis of various organs 
such as the liver, lungs, and kidney, but the exact role of EMT was under heated debate for 
decades [55-57]. One proposal is that epithelial cells undergo EMT and contribute to the 
population of myofibroblasts in injured tissues. However, LeBleu et al used a lineage tracing 
approach and showed that transition of the tubular epithelial cell to myofibroblast contributes to 
just 5% of all the possible sources including resident fibroblasts proliferation, bone marrow and 
endothelial-to-mesenchymal transition program [53]. Later, two studies demonstrated that most 
tubular epithelial cells undergo pEMT instead of full EMT [58, 59]. Those tubular cells in the 
pEMT state stay in the original place and do not transit to myofibroblasts directly. Instead, they 
secrete multiple cytokines, such as TGF-β and WNT, and indirectly promote activation and 
		
proliferation of myofibroblasts. Both studies show that perturbation of pEMT, such as by 
knockout of SNAIL1 or another EMT regulator TWIST1, significantly recedes renal fibrosis 
induced in a mouse kidney injury model. Taken together, these two papers demonstrated that 
pEMT instead of full EMT contributes to the progression of renal fibrosis and may be a potential 
target for pharmaceutical intervention.  
The observation that pEMT contributes detrimentally to fibrogenesis raises an intrigue question: 
why is the pEMT program activated during the process of repairing kidney injury? Tian et al. 
performed combined mathematical modeling and mouse ischemic reperfusion injury model 
studies and showed that pEMT cells serve an important role of relaying and amplifying signals 
to recruit injury repair cells and accelerate the repair process [60]. In normal conditions, 
fibroblasts exist in a very low density and sparsely reside within the narrow interstitial space 
between kidney functional units called nephrons [58]. Injured nephrons send extracellular 
signals such as WNT to activate and recruit fibroblasts and other immune cells. However, WNT 
molecules have a short half-life and mainly mediate close-range signaling [61-63]. Furthermore, 
WNT diffusion within the tortuous and narrow interstitial space is likely subdiffusive, as 
anomalous diffusion has been observed in similar narrow brain extracellular spaces [64-70]. 
Therefore, diffusion alone is not efficient to propagate the repair signals from an injury site to 
distant sites for recruiting injury-repair cells. Instead along the way of diffusion WNT molecules 
induce tubular epithelial cells to undergo pEMT, and the pEMT cells secrete their own WNT 
molecules and serve as repair “signal relay and amplification stations”. This relay mechanism is 
necessary and critical for sending repair signals over long distances, possibly in the form of 
spatial trigger waves [71]. Disruption of this process slows down the repair process and 
increases the risk of death after AKI. After injuries are repaired, the inflammatory response 
needs to be resolved, so the pEMT cells convert back to epithelial cells, and myofibroblasts 
either undergo apoptosis or convert back to resident fibroblasts. Incomplete resolution 
		
characterized by residual pEMT cells leads to sustained myofibroblast activation and fibrosis 
development. Therefore, pEMT facilitates quick repair. However, excessive pEMT also 
increases the risk of fibrosis, and these two opposite effects were indeed observed in mouse 
model studies. Thus, the potential severity and lethality of AKI can explain why a repair system 
has evolved that exploits pEMT for augmented and accelerated repair, even at the expense of 
increased risk of chronic disease.	 
Realizing that pEMT activation is a double-edged sword also has profound medical implications. 
Effective biomedical intervention must take into account the nonlinear dynamic nature of a 
biological system, as opposed to simply modulating selected pharmaceutical targets 
monotonically. Tian et al. showed that a sequential application of WNT agonist and antagonist 
reduces rates of both mouse death and fibrosis development [60]. 
3. Iterations between experiments and modeling uncovered a mechanism how cells 
interpret quantitative signaling information to decide on EMT commitment. 
As shown in the two above examples, multiple stimuli such as TGF-β, sonic Hedgehog (SHH), 
and WNT can induce EMT [4]. This existence of multiplex EMT inducing stimuli might seem 
unexpected since under most in vivo conditions normal epithelial cells need to maintain the 
phenotypic integrity despite stochastic fluctuations of environmental and intrinsic factors. An 
answer to this paradox resides in realization that cells read and respond to quantitative 
information of the stimuli and make a cell fate decision accordingly. That is, only specific signals 
(or combinations of signals) exceeding a certain threshold of strength and duration can induce 
EMT/partial EMT (Fig. 3A) [38]. Therefore, detection and transmission of the temporal quality of 
the stimulating signals is an important cellular mechanism in regulating the downstream 
effectors.  
Following an iterative procedure between measurements and modeling, Zhang et al. revealed a 
		
composite network for TGF-β duration detection and regulation of SNAIL1 activation (Fig. 3B) 
[72].  The network can be divided into three modules: the canonical TGF-β-SMAD-SNAIL1 
network as an early response module, a late response module formed by a GLI1-mediated 
positive feedback, and GSK3 that bridges the two modules. A short pulse of TGF-β activates 
SMAD but not GLI1 and generates only transient SNAIL1 expression; a pulse exceeding 
thresholds both in strength and duration or sustained TGF-β exposure activates both SMAD and 
GLI1 to generate two waves of SNAIL1 expression. Consequently, cells can respond 
differentially depending on TGF-β duration. Inhibition of GLI1 increases the duration threshold to 
activate the second wave of SNAIL1.  Notice either pSMAD2/3 or GLI1 can distinguish only 
certain range of TGF-β duration. For example, the temporal profile of pSMAD2/3 may 
distinguish well between the absence of a TGF-β pulse and a short TGF-β pulse (e.g., 1-2 hours 
for human MCF10A cells), but may not be able to do so between short and long (e.g., > 2 hours 
for MCF10A cells) pulses; GLI1, on the other hand, can distinguish between short and long 
pulses. Then a combination of the two signaling proteins may encode the information for a 
broader range and lead to TGF-β duration-dependent SNAIL1 expression patterns. This 
scheme can be further extended with more readouts included.  
In cell signaling there is an apparent paradox between the measured puzzling limited 
information content from the dynamic profile of one readout [73, 74] and the remarkable 
accuracy of cellular signaling. The work of Zhang et al. [72] suggests a possible solution would 
be for cells to use multiple readouts to form a temporally-ordered state space (TOSS) to encode 
the signal information. Consider a coarse-grained model for coding the TGF-β duration 
information with two readouts (pSMAD2/3 and GLI1). Assume that each readout can exist in two 
distinct states (0 and 1) and show statistically uncorrelated dynamics at two (coarse-grained) 
time points. Theoretically, the two readouts form a TOSS with 16 as the maximum number of 
states and can carry a maximum information capacity of four bits. Therefore, cells can interpret 
		
and transmit high content information, analogous to a computer chip using combinations of 
multiple binary gates.  
As for EMT studies, SNAIL1 is highly pleiotropic and is a key regulator of EMT [75], so the 
detected rich temporal dynamics of Snail1 by Zhang et al. also shed light on understanding how 
cells make a decision to commit to EMT. The uncovered network serves as a temporal 
checkpoint that prevents spurious SNAIL1 activation and subsequent major cellular fate 
changes by transient fluctuations of EMT inducing factors. Under pathological conditions, a 
reduced threshold for activating sustained SNAIL1 expression likely contributes to a tilt of 
balance towards cell survival through EMT instead of apoptosis [76]. 
4. Selected topics for future quantitative studies  
In a larger context, the EMT program is coupled to the networks regulating many other 
biological processes such as cell cycle and stemness. It remains an active research area on 
examining how these programs are coupled to and interfere with EMT, and how a cell makes a 
fate choice. There are already many extensive reviews focusing on tumorigenesis, cancer 
metastasis [77-82], drug resistance [83], and crosstalk with other signaling pathways including 
SHH and WNT [84]. We anticipate that quantitative approaches with combined computational 
modeling and experimental measurements will continue to complement other more traditional 
approaches and provide important insights to the regulation and physiological roles of EMT 
under different contexts. Given a potentially long list of problems and many existing reviews, 
below we will focus on a few selected topics that have been less emphasized previously. 
4.1. EMT and Cell Cycle Arrest  
Cells transiently enter cell cycle arrest during the course of EMT, but details on how the two 
processes are coupled remain unclear. TGF-β1--induced EMT is directly associated with P21-
mediated G2 arrest in tubular epithelial cells [85]. Both TWIST1 and SNAIL1 induce P21-
mediated G2 arrest in renal fibrosis [58]. Interestingly, in mouse AML-12 cells TGF-β1 induces 
		
EMT only at the G1/S phase, while it induces apoptosis at the G2/M phase [86]. It is also 
reported that TGF-β1 and TGF-β3 play separate roles in cell cycle arrest and EMT [87]. 
Following cell cycle arrest induced by TGF-β1, TGF-β3 executes EMT and apoptosis [87]. Thus, 
it has been suggested that cells cease cell cycle as a prerequisite to facilitate EMT. Consistent 
with this requirement of cell cycle arrest, EMT is often associated with low proliferation but high 
invasive ability. Cells undergoing EMT also acquire resistance to two safeguard mechanisms: 
senescence and apoptosis [3].  
Existing studies suggest that EMT and the cell cycle are coupled at various stages and can be 
cell-type specific. Here we summarize two hypothetical coupling schemes (Fig. 4). In both 
schemes, cells first have an increased concentration of P21/SNAIL1 and undergo cell cycle 
arrest and partial EMT (state Pα). The depth of the partial EMT state Pα depends on the level of 
P21, analogous to the depth control of cellular quiescence by an Rb-E2F switch [88], and 
sufficiently high concentrations of P21 may drive cells to the largely irreversible senescent state. 
The main difference between the two schemes is whether cells exit cell cycle arrest before 
(scheme 1 with another pEMT state Pβ), together with (scheme 2), or even after completion of 
EMT. Mechanistically, various factors regulate EMT and the cell cycle differently. Specifically, 
SNAIL1 has been shown to mainly initialize EMT and up-regulate P21, while TWIST1 is 
activated at a later stage to maintain EMT but represses P21 expression [89-91]. Different 
strengths of these interactions may result in either scheme 1 or 2, and quantitative 
measurements such as time-lapse single cell imaging are needed to distinguish these 
competing mechanisms.  
4.2. EMT and Apoptosis 
It is intuitive to think that EMT and other cell fates such as apoptosis are mutually exclusive. 
EMT is considered as a mechanism for cancer cells to escape from and survive through 
		
stressful conditions [92, 93]. This understanding is complicated by a recent study reporting an 
unexpected observation that in pancreatic ductal adenocarcinoma (PDA) cells EMT precedes 
apoptosis [94]. Both TGF-β induced EMT and SOX4 expression are generally considered pro-
tumorigenic. SOX4 requires a transcription factor KLF5 as a cofactor to be anti-apoptotic and is 
pro-apoptotic without KLF5. However, in TGF-β sensitive cells, the TGF-β-SMAD-SNAIL 
pathway induced EMT represses KLF5. Therefore, crosstalk between the two presumably pro-
tumorigenic pathways results in SOX4-induced lethal apoptosis. This surprising observation 
exemplifies the complexity and context-dependence of cell fate decision programs.  
Another intriguing EMT related phenomenon is called anastasis, as opposed to apoptosis. 
Under stress a cell first appears to undergo apoptosis with apparent morphological change, then 
survives and switches to EMT instead. This process has been observed in multiple cell types 
and has become an active research area recently [95-97]. Figure 5 shows three human renal 
epithelial HK2 cells undergoing significant morphology change under TGF-β treatment. In the 
top, a cell underwent partial and then full EMT. It changed step-by-step from a regular polygon 
shape into a larger and spindle-shaped cell, characteristic of EMT. In the middle, a cell 
underwent apoptosis with membrane blebbing. The bottom shows an example of anastasis 
followed by EMT. This cell first showed membrane blebs, indicating that it was undergoing 
apoptosis, but then the cell managed to recover from apoptosis and undergo EMT instead.  To 
understand the molecular mechanism of anastasis, Sun et al performed a transcriptome 
analysis of untreated, apoptotic and recovering human HeLa cells [96]. Their data challenged 
the traditional view that caspase activation is a no-return point for apoptosis. Instead, they found 
that mRNAs of some genes including snail, which are required for recovery from apoptosis, are 
transcribed but not translated when caspase is still activated. That is, cells are poised for 
recovery even when the apoptosis program is under execution, so they can recover quickly and 
undergo EMT if the apoptosis stress is removed. The observation that the process of apoptosis 
		
remains reversible even at a very late stage of the process raises a question that requires a 
quantitative answer: when is the no-return point of apoptosis?	 Computational modeling in 
combination with quantitative measurements will be useful in answering such a question. 
4.3. EMT and Stemness 
As discussed in section 1, the EMT regulatory program couples to a number of other cellular 
programs with shared regulators and crosstalk. Specifically, the possible relation between EMT 
and stemness in cancer cells has raised lots of attention [98-101]. The cancer stem cell (CSC) 
theory is a heatedly debated hypothesis on cancer heterogeneity and drug resistance [99, 101-
106]. Originally the theory states that a fraction of cancer cells have the capacity of self-renewal 
and differentiation into other cancer cell types to sustain the cancer cell population, much like 
normal stem cells. Recent studies suggest that unlike normal stem cells, CSCs may come from 
dedifferentiation of non-CSCs [83, 107-109]. In an influential study, Weinberg and coworkers 
showed that induction of EMT in immortalized human mammary epithelial cells generates cells 
with stem cell properties [110]. Similarly, Morel et al. showed that activation of the RAS-MAPK 
pathway induces stemness characteristics in human mammary epithelial cells [111]. The two 
studies led to an explosive number of studies on the relation between EMT and CSC generation 
[99]. Notably Jolly et al. analyzed a combined EMT/stemness gene regulatory circuit and 
suggested that one can fine-tune the positioning of the stemness window along the EMT axis 
[79].  
Here we propose a general strategy to study the coupling between EMT and stemness 
phenomenologically using breast cancer cells as an example system. First consider the EMT 
and stemness regulation separately. While the EMT axis is likely a continuum, for simplicity of 
discussion we consider three coarse-grained EMT phenotypes, E, P, and M. In practice two 
surface markers, CD44 and CD24, are widely used in breast cancer studies. Similarly, we 
		
consider two coarse-grained stem states, cancer stem-like cells (CD44highCD24low, denoted as 
“S” in the following discussions) and non-stem-like cells (CD44lowCD24high, denoted as “N”) [110]. 
If the EMT and CSC programs are weakly coupled, each program maintains the identity of its 
own state, and is only weakly perturbed by cross-talking with another one.  Then one expects a 
complete state network with a total of six possible states with all possible transitions among 
them (Fig. 6A). On the contrary, if the two programs are strongly coupled, the number of 
populated states may be less since the EMT state of one cell may determine its stem state and 
vice versa. Notice that there are three EMT states but only two CSC states that have been 
identified. Then the relation between the “P” state and CSC states is unclear. Figure 6B &C 
show two possibilities and plausible pathways for the transitions, with the P state coupling to the 
N state in one pathway, and to the S state in another one. Potentially, another intermediate 
state CD44mediumCD24medium,	 may exist, which would further complicate this roadmap. 
Establishing such a map of the EMT-CSC state network is of great importance not only for 
understanding cell phenotype transition, but also for developing effective cancer treatment 
strategies. Experimentally, one can distinguish the different schemes through multi-color flow 
cytometry with both EMT and stemness markers. More generally one can represent the coupled 
process with a continuous two-dimensional surface composed with the EMT and stemness axes. 
The proposed framework can also be applied to other processes coupled to EMT. From a 
theoretical perspective, the framework is analogous to representing an interacting many-particle 
system with a single-particle diabatic representation in quantum chemistry. 
4.4. EMT and epigenetics 
Epigenetic regulation is also an essential part of EMT regulation [14]. McDonald et al. examined 
TGF-β induced EMT of AML12 mouse hepatocytes [112]. During EMT, the global level of DNA 
methylation was barely changed, yet H3K9Me3 was reduced, and H3K4Me3/H3K36Me3 was 
increased on the genome-scale [112]. In another study on primary human mammary epithelial 
		
cells, Dumont et al. showed that epigenetic change during EMT has a determined temporal 
order, with inhibition of E-Cadherin transcription preceding methylation of its promoters. 
Furthermore, EMT transcription factors actively participate in the process of epigenetic 
regulation. For example, TWIST inhibits E-cadherin transcription by interacting with the 
deacetylase (Mi2/NuRD) complex, MTA2, RbAp46, Mi2 and HDAC2 [113]. SNAIL1 is able to 
recruit histone demethylase LSD1 to remove the dimethylation on H3K4me2 and thus promotes 
further repression of its targets including E-cadherin [114]. SNAIL1 can cause bivalent histone 
modifications of target gene promoters, which have both active marker H3K4me3 and 
repressive marker H3K27me3 [115]. Specifically, the bivalent epigenetic state was also found at 
the ZEB1 promoter, which enables breast cancer cells to be more plastic and enhances 
tumorigenicity [116]. It is noted that the bivalent epigenetic state is a poised state that renders a 
gene susceptible to reactivation [116]. We suggest that this is a possible feature of the pEMT 
state, which is reversible in both phenotypic level and epigenetic level. Taken together, 
integrated regulation at different layers greatly enhances both stability and plasticity of EMT 
phenotypes. This coupling is supported by the observed correlation among expression, gene 
spatial proximity, and histone modification patterns of genes regulated by common transcription 
factors in TGF-β treated MCF10A cells [117].  
Physics-based models have been used to study how the coupling of epigenetic and genetic 
regulation controls cell fates [118-123]. Previously, Zhang et al. constructed a Potts-type model 
for epigenetic histone modification and showed that lateral interaction between nearest-neighbor 
enzymes is sufficient for collective epigenetic states [119]. Then by applying the epigenetic 
modeling framework to the differentiation process of olfactory sensory neurons, a theoretical 
model study by Tian et al. shed light on an intriguing puzzle about the ‘one-neuron, one-receptor’ 
phenomenon [118]. Their multiscale model by coupling the genetic and epigenetic regulation 
demonstrated how the physical principle of cooperativity provides a mechanistic explanation of 
		
this challenging biological problem. In future work, we expect to see more such model studies 
on describing the dynamics aspect of the coupling between epigenetic modifications and other 
mechanisms of gene regulation such as chromosome structure and transcription factors on 
regulating the dynamics and spectrum of EMT. 
4.5. Quantitative single cell techniques emerge as important tools for EMT studies 
Various methods and techniques have been introduced to address the above discussed and 
other EMT-related problems. Among them, single cell techniques emerge as powerful tools. 
Many intrinsic and extrinsic factors, such as cell density, cell cycle stage, and fluctuations of 
intracellular EMT regulator concentrations, may affect whether a cell commits to EMT and how 
fast that conversion process proceeds. Single cell studies are informative on dissecting the 
effects of these factors. We have discussed several studies using fixed cell-based techniques 
such as flow cytometry and fluorescence staining [39, 42, 72, 124, 125]. Single cell 
transcriptome studies have also been applied for understanding the roles of EMT in 
organogenesis and disease development [126-129].  Using live cell imaging at single cell 
resolution, Kuo and Krasnow recorded a slithering mode of cell migration during formation of 
ling neuroepithelial bodies, where cells transiently and partially lose epithelial characters and 
migrate to a next-neighboring site without completely detaching from the epithelium membrane 
throughout the process [130]. Using combined fixed and live cell imaging, Burute et al. observed 
centrosome repositioning during the process of EMT [131]. Compared to fixed cells, live cell 
studies provide information on the temporal correlation of intracellular dynamics for individual 
cells but are technically more challenging. Below we will review a few recent technical advances 
that are expected to facilitate single cell imaging studies on EMT. 
Quantitative single cell image analysis starts with single cell segmentation to identify and outline 
regions of interest in an image, which is necessary for subsequently extracting quantitative 
single-cell information [132-134]. Accurate segmentation is also a prerequisite for cell tracking 
		
since errors of cell segmentation propagate along single-cell trajectories. For EMT studies 
tightly packed epithelial cells further increase the difficulty of correct cell segmentation. Several 
commonly used tools ImageJ [135] and CellProfiler [136] typically require time-consuming and 
labor-intensive fine-tuning of multiple parameters manually, which quickly becomes impractical 
with a large amount of time-lapse images. Machine learning based automated image analysis 
methods have become alternative choices in recent years [137]. Van Valen et al. showed that 
for segmenting live cell images deep convolutional neural networks (DCNN) significantly 
outperform other conventional methods both in accuracy and required efforts [138]. Wang et al. 
developed a method that combines the strength of DCNN and the conventional watershed 
algorithm, which segment densely packed epithelial cells with improved accuracy compared 
with direct application of DCNN [139].  Eschweiler et al. also showed that preprocessing 3D 
confocal images with CNN improves the accuracy of watershed-based segmentation [140]. 
For fluorescence-based imaging, generating cell lines with fluorescence labeling is another 
challenge, and the advent of CRISPR-based techniques greatly accelerate such processes. 
CRISPR-based endogenous knock-in labeling is desirable for quantitative biology studies since 
the “tagged” proteins are not overexpressed, and cellular dynamics are thus less perturbed. 
CRISPR-based gene knock-in can also facilitate generating model systems such as a fusion 
gene for cancer development. Knock-in is technically more challenging than knock-out. One 
possibly unexpected challenge is generating donor DNAs that contain the specific knock-in 
sequence and repair templates. Chen et al. developed an efficient and modular assembly 
procedure, which also allows convenient fusion of single guide RNAs (sgRNAs) to the 
constructs to achieve additional enhanced homology-directed repair efficiency [141]. Li et al. 
also developed an optimized procedure for synthesizing single-stranded DNA donors for 
CRISPR knock-in [142]. 
		
Chen et al. illustrate their procedure specifically for inserting fluorescence protein sequences 
into targeted genes [141]. The procedure can also be applied to generate cell lines for mRNA 
tagging. In this method, one needs to insert multiple copies of stem-loop sequences that can 
recruit RNA binding proteins such as MS2 fused with fluorescence proteins [143]. Difficulties of 
generating the cell lines have greatly limited its use in previous studies, and the advent of 
CRISPR techniques could drastically change the situation. 
EMT is accompanied with a large chromosomal reorganization. Tracking the process can 
provide useful insight into how cells maintain phenotypic stability and plasticity. Besides fixed 
cell-based techniques such as Hi-C and FISH, CRISPR has been repurposed for labeling 
specific genomic loci in live cells with catalytically dead Cas9 (dCas9) fused with fluorescence 
proteins, or by extending sgRNAs with stem-loops that can recruit RNA binding proteins fused 
with fluorescence proteins [144-158]. The Xing lab is currently using this technique to study 
chromosome dynamics during EMT. 
The CRISPR-Cas9 system has also been repurposed to regulate gene expression directly or 
edit epigenetic histone modifications and DNA methylation [159-161]. In both cases, sgRNAs 
recruit dCas9 fused with certain effectors to specific genomic locations. These techniques may 
be used for reversing the EMT process. One such target is the miR-200 family, where 
repressive histone marks and DNA methylation inactivate expression of members of this pro-
epithelial miRNA family in many invasive cancer types showing mesenchymal and stem-like 
features [162, 163]. These techniques permit expression control of selective EMT related genes 
and can combine with other approaches such as optogenetics to achieve precise 
spatiotemporal control for single-cell studies. 
5. Discussion and concluding remarks 
		
Quantitative studies on EMT, both from experimental and theoretical perspectives, have only 
emerged recently, which already make it unfeasible to provide a thorough review here. We 
expect to see a rapid growth of such studies with new approaches and concepts from physics. 
Below we provide some perspective based on our own experiences. 
The network is dynamic and cell type-specific. It is a standard practice to reconstruct biological 
networks from results obtained with different cell types and different stages of a dynamical 
process. The information is often static and incomplete. Therefore, caution needs to be taken on 
performing computational analysis of these networks.  
In physics, one seeks general principles, which is challenged by diversity and heterogeneity of 
biological systems. It is unlikely to find a single model that can fit all the contexts. General 
principles, however, still exist at more abstract levels. For example, EMT studies demonstrate 
that coupled positive/negative feedback motifs are key network structures for regulating cell 
phenotypes [38, 41, 42]. 
Iteration between mathematical modeling and quantitative measurements is fruitful on 
advancing our understanding of EMT dynamics. Within a foreseeable future, it is unlikely that 
one can perform first principle type studies for complex biological systems such as EMT. 
Instead, a close and iterative interplay between modeling and experiments will remain as a 
necessary main theme.  In their studies, Zhang et al. [72] first examined a simple mechanism 
based on available knowledge of TGF-β signaling, which states that the TGF-β induced 
pulsating SMAD2/3 activation initializes SNAIL1 expression, which is then self-maintained by 
the SNAIL1-miR-34 double-negative feedback loop. The mechanism is both biologically 
plausible and theoretically attractive but is insufficient to explain their quantitative time course 
data. The discrepancy led to their subsequent computational and experimental investigation that 
unravels the three-module network discussed in section 1. Notably following this iterative 
		
procedure the researchers discovered a new phenomenon of TGF-β signaling [72]. It is well 
documented that TGF-β leads to conversion of the GSK3 family proteins to a serine (S21 in 
GSK-3α and S9 in GSK-3β) phosphorylation form that is enzymatically inactive. Through 
computational analysis, these researchers found that this canonical GSK3 pathway could not 
explain a multi-phasic dynamics of GLI1, which is a downstream substrate of GSK3. Instead, 
immunostaining studies revealed that TGF-β first induces accumulation in the Golgi apparatus 
and endoplasmic reticulum of GSK3 in a much less studied tyrosine (Y279 in GSK-3α and Y216 
in GSK-3β) phosphorylation form with increased enzymatic activity. This transient localization 
change has surprisingly escaped notice despite decades of extensive studies on TGF-β signal 
transduction. It is possibly due to the fact that this active form is only ~10% of the total GSK3 
molecules and this percentage does not change significantly throughout TGF-β treatment, 
rather the change is mainly their cytoplasmic location. Zhang et al. further demonstrated that 
this increased local concentration of GSK3 active form has subtle but important functions on 
accelerating GLI1 accumulation upon TGF-β stimulation [72]. Further studies can examine 
whether spatial accumulation of the tyrosine phosphorylation form of GSK3 involves phase 
separation [164], and if so how the GSK3 solubility in different phases is modulated upon TGF-β 
treatment. Therefore, this discovery of new biology and subsequent emergence of new 
questions demonstrate the power of the iterative approach between modeling and quantitative 
measurements. 
Similarly, constructive scientific debates also take place among modelers. In their original work, 
Tian et al. used a phenomenological form to model microRNA-mRNA mutual regulations [38]. 
Lu et al. pointed out the importance of treating these interactions more explicitly [41]. The latter 
prompted a further theoretical analysis that revealed surprisingly rich dynamics just with a 
simple microRNA-mRNA mutual regulation motif [40]. 
Studies focusing on a minimal abstract network and an extended detailed network are 
		
complementary. At the technical level, there are two general classes of approaches of studying 
a regulatory network. One is to start from a network that includes as many relevant molecular 
species as possible. The resultant hope-to-be-exhaustive network is large and can provide a 
direct comparison with many available experiments and make specific predictions. It is also 
straightforward to incorporate high throughput screening data such as microarray and RNA-seq 
into the model. The downside is that the number of adjustable parameters of a corresponding 
mathematical model heavily out-numbers possible constraints from feasibly available 
experimental data. Consequently, it is difficult to perform an inclusive analysis of the model. One 
approach is to sacrifice some quantitative features, for example, by performing Boolean type 
modeling or further network reduction. Another one is to aim at identifying a minimal network 
that sufficiently and quantitatively describes the dynamics of a process. The network is typically 
much smaller and is amenable for thorough analysis. The corresponding model has limited 
power to predict elements not explicitly considered in the core network. On the other hand, the 
small size of the network makes it feasible to be integrated with data-intensive quantitative 
measurements on the involved molecular species, and the interplay between modeling and 
quantitative data allows an expansion process from the core network to achieve one or a set of 
minimal and inclusive models.  
Therefore, both approaches are complementary, each having their strengths and limitations. 
Both have been successfully used to address various questions, specifically in analyzing the 
EMT regulatory networks [38, 39, 41, 165]. An extended network can provide global dynamics 
with less resolution on the temporal evolution of individual constitute elements, and a minimal 
network can provide a quantitative description of a small number of network elements. For a 
specific problem, the choice of which approach to use should depend on the objective of the 
study and availability of data.   
The above issue relates to some general theoretical challenges especially for systems out of 
		
thermodynamic equilibrium, such as how to reconstruct system dynamics from experimental 
data with a limited number of observables, and how to describe the dynamics of a primary 
system strongly coupled to a larger “environment”. Xing and Kim derived a generalized 
Langevin equation using the Zwanzig-Mori projection formalism for systems without detailed 
balance [166]. In this formalism effects of the possibly infinite number of environmental degrees 
of freedom on the primary system are parameterized by a memory kernel and in general colored 
noise, similar to the case that solvent effects on a Brownian particle are modeled by a drag 
coefficient and white noises. Hilfinger et al. analyzed constraints that unspecified network 
components impose on fluctuations of the “primary” components being observed [167, 168]. 
The analysis separates properties of fluctuations due to local interactions within a primary 
system from influences from the coupled environment. Further theoretical development and 
applications will be desirable. 
As concluding remarks, EMT is a fascinating biological process that physicists can provide 
unique insights on questions raised by biologists. Furthermore, it can also serve as a model 
system for which physicists can define physics-oriented questions such as transition dynamics 
and paths between nonequilibrium attractors. 
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Legend: 
Figure 1. Example mathematical analysis of EMT regulation. (A) EMT proceeds through 
partial EMT states. (B) The core regulatory network regulates TGF-β-induced EMT. (C) 
Bifurcation analysis of the mathematical model predicts a Cascading Bistable Switches (CBS) 
mechanism with three EMT phenotypes: Epithelial state, partial EMT state (mixed feature of 
epithelial and mesenchymal states), and Mesenchymal state. E-cadherin and Vimentin are 
epithelial and mesenchymal markers, respectively. Pointed and blunt-ended arrows represent 
activation and inhibition, respectively. Adapted from [39].  
Figure 2 Single cell flow cytometry data of human MCF10A cells treated with different 
concentrations of TGF-β supports the CBS model. E, P, and M refer to the epithelial, pEMT, 
and mesenchymal states, respectively. Adapted from  [39]. 
Figure 3 Cells commit to EMT only after receiving stimuli with strength and duration 
above certain threshold values. (A) Model prediction that TGF-β with different duration and 
strength induces different EMT states. Adapted from [38]. (B) Schematic of the pathway 
crosstalk model revealed through combined modeling and quantitative experiments. 
Figure 4 Two possible coupling mechanisms between EMT and cell cycle arrest. (A) 
Scheme1 predicts four possible cell states, Epithelial, partial EMT-α (Pα), partial EMT-β (Pβ), 
Mesenchymal. (B) Scheme 2 predicts three cell states with only one partial EMT state (Pα) 
associated with cell cycle arrest. It is noted that Pα is under cell cycle arrest and thus non-
proliferative while Pβ is proliferative. The stability or the depth of the partial EMT state Pα 
depends on the level of P21. 
Figure 5 Human HK2 cells treated with TGF-β undergo different cell fates as reflected by 
morphological change. Cell shapes were analyzed from time-lapse movies. Unpublished data 
from the Xing lab. 
Figure 6 Possible state networks of the EMT-CSC system. (A) Complete state network with 
weak coupling between the two programs. (B) Partially populated state network with strong 
coupling, so only some transition pathways dominate. (C) Alternative possible partially 
		
populated state network with dominated pathways different from panel B. Solid arrows represent 
the dominating pathways. 
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